| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 12 | -687,226 | 100% | $25.50 | -$17,521,456 |
| Net | -12 | -687,226 | -100% | -$17,521,456 |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Morningside Venture Investments Ltd | 10%+ Owner | $815,635,922 | 18 Nov 2021 | ||
| Cedric Francois | Chief Executive Officer, Director | $51,689,812 | -$10,419,501 | -17% | 27 Aug 2025 |
| Alec Machiels | Director | $19,212,760 | 01 Jan 2026 | ||
| Timothy Sullivan | Chief Financial Officer | $10,108,217 | -$1,694,615 | -14% | 21 Oct 2025 |
| LUKAS SCHEIBLER | Chief Research Officer | $6,961,586 | 01 Dec 2023 | ||
| Federico Grossi | Chief Medical Officer | $6,043,162 | 05 Jan 2023 | ||
| Pascal Deschatelets | Chief Scientific Officer | $5,963,139 | -$232,645 | -3.8% | 09 Jun 2025 |
| David Watson | General Counsel | $5,350,559 | -$1,794,406 | -25% | 16 Dec 2025 |
| Nur Nicholson | Chief Technical Officer | $4,069,737 | -$284,281 | -6.5% | 09 Jun 2025 |
| Kelley Boucher | Chief People Officer | $4,034,395 | 02 Sep 2025 | ||
| Mark DeLong | Chief Business & Strat Officer | $3,995,365 | -$146,503 | -3.5% | 09 Jun 2025 |
| Caroline Baumal | Chief Medical Officer | $3,928,045 | -$132,609 | -3.3% | 05 Jan 2026 |
| Sinclair Dunlop | Director | $3,817,828 | -$2,153,155 | -36% | 01 Jan 2026 |
| Victoria Brown | Program Team Lead | $3,142,798 | 20 Jan 2023 | ||
| Adam Townsend | Chief Commercial Officer | $2,481,459 | -$264,626 | -9.6% | 29 Jan 2025 |
| Karen Lewis | Chief People Officer | $2,074,062 | -$147,094 | -6.6% | 29 Jan 2025 |
| LESLIE MELTZER | Chief Research and Development | $1,726,185 | 26 Aug 2025 | ||
| James Chopas | VP/Chief Accounting Officer | $1,724,664 | -$101,741 | -5.6% | 15 Sep 2025 |
| Jeffrey Eisele | Chief Development Officer | $1,633,009 | -$55,064 | -3.3% | 29 Jan 2025 |
| R. PAUL FONTEYNE | Director | $1,105,729 | 01 Jan 2026 | ||
| CRAIG WHEELER | Director | $1,090,760 | 01 Jan 2026 | ||
| Gerald Chan | Director | $987,579 | 01 Jan 2026 | ||
| Stephanie O'Brien | Director | $987,579 | 01 Jan 2026 | ||
| Keli Walbert | Director | $910,719 | 01 Jan 2026 | ||
| Nicole Perry | Vice President - Accounting | $717,179 | 02 Aug 2021 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|